← All Sponsors
SPONSOR

Rutgers, The State University of New Jersey

Total Trials
14
Recruiting
14
Phases
Phase 3, Phase 2

Rutgers, The State University of New Jersey is a clinical research sponsor with 14 registered studies on ClinicalTrials.gov, of which 14 are actively recruiting participants. Research covers conditions including Opioid Use Disorder, Posttraumatic Stress Disorder (PTSD), Substance Use Disorders (SUD), Comorbidity.

The trial portfolio spans Phase 3, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Rutgers, The State University of New Jersey

How many clinical trials has Rutgers, The State University of New Jersey sponsored?
ClinicalMetric currently tracks 14 clinical trials sponsored by Rutgers, The State University of New Jersey, of which 14 are actively recruiting participants. These trials cover conditions including Opioid Use Disorder, Posttraumatic Stress Disorder (PTSD), Substance Use Disorders (SUD). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Rutgers, The State University of New Jersey research focus on?
Rutgers, The State University of New Jersey clinical trials span Opioid Use Disorder, Posttraumatic Stress Disorder (PTSD), Substance Use Disorders (SUD), Comorbidity, Trauma and Stressor Related Disorders, and additional conditions. The research pipeline includes Phase 3, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Rutgers, The State University of New Jersey clinical trial?
To participate in a Rutgers, The State University of New Jersey trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Rutgers, The State University of New Jersey trials with current recruitment status updated daily.

Clinical Trials by Rutgers, The State University of New Jersey

NCT05589181 Phase 3
Recruiting

High Dose Buprenorphine (BUP) Induction in the Emergency Department (ED)

Opioid Use Disorder
NCT06968832
Recruiting

Project COMET: Massed Prolonged Exposure for PTSD and SUD

Posttraumatic Stress Disorder (PTSD)
NCT06072963 Phase 2
Recruiting

COMMETS- Combination MCI Metabolic Syndrome

Alzheimer Disease
NCT07316192
Recruiting

Pelashield™ PainGuard™ vs Restrata® in HS Surgery

Hidradenitis Suppurativa (HS)
NCT07378254
Recruiting

Finding Emotional Empowerment and Lifelong Strength

Trauma and Stressor Related Disorders
NCT06555094
Recruiting

Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App

Suicidal Ideation
NCT07171684
Recruiting

Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)

Diabetes in Pregnancy
NCT05296421
Recruiting

Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma
NCT05794087
Recruiting

The Role of Macrophage Activation in Lung Injury Following Ozone Exposure

Air Pollution
NCT07217535
Recruiting

Rutgers University Study of the Genetics of Kidney Disease

Kidney Disease
NCT05801861
Recruiting

Modulating Goal-directed Navigation Using Noninvasive Brain Stimulation

Spatial Navigation
NCT02688517
Recruiting

Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

Malignant Neoplasm
NCT07011472
Recruiting

Post-Operative Analgesic Selection in Patients Planned for Third Molar Extraction After Undergoing Shared Decision Making Using 2- Versus 3-Option Decision-Aids

Pain Management
NCT05366829 Phase 2
Recruiting

Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma

Carcinoma, Hepatocellular
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology